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Low grade inflammation has been recognized of being involved in the pathogenesis of 
chronic disease pandemic. Individual lifestyle plays a major role in the development of low 
grade inflammation. Sedentary workers are at risk of low grade inflammation due to the 
nature of their work. Dietary habit also contributes to inflammatory status in the body. 
Dietary fiber intake indirectly affects the immune system. It has been hypothesized that 
fiber has anti-inflammatory effects, both body weight-related and body weight-unrelated 
This review will focus more on body weight-unrelated anti-inflammatory effect of fiber, 
especially through fiber’s fermentation metabolites, the short chain fatty acid (SCFA). Its 
anti-inflammatory effect can be seen by monitoring a biomarker of inflammation in the 
body, the high sensitivity C-reactive protein (hsCRP). This review’s objective is to cover the 
mechanisms and role of dietary fiber intake on serum hsCRP level as a marker of low grade 
inflammation on sedentary workers. 
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Introduction 
 
Inflammation is the body’s response over harmful 
stimuli which leads to the activation of various 
mechanisms on a molecular level. Depending on the 
severity, inflammatory reaction could be seen 
locally or generalized throughout the body.1 There 
are many causes of inflammation such as bacteria, 
tissue damage, or metabolic stress.2 Low grade 
inflammation is a type of chronic, asymptomatic 
inflammation.3 Low grade inflammation has been 
hypothesized to be a cause of insulin resistance, 
dyslipidemia, atherogenesis, type 2 diabetes, and 
hypertension.4 Risk factors for low grade  
 
inflammation are imbalance diet leading to 
overweight and obesity, smoking, and low level of 
physical activity.3 These risks are commonly seen on 
sedentary workers in large cities. Their lifestyle is 
closely related to their work demand, which causes 
them to spend a majority of their time doing 
sedentary activities, having low physical activity, a 
smoking habit, and consumes high fat diet.5,6 All 
together, these factors contribute to the development 
of low grade inflammation which may result in 
declining of working productivity.7 
A laboratory examination occasionally used to 
detect low grade inflammation is high sensitivity C-
reactive protein  (hsCRP), a value of >1 mg/L marks 
the presence of low grade inflammation.8 During an 
acute phase of inflammation, CRP is primarily 
synthesized by the liver and is actively involved 
during the course of inflammation.9,10 Chronic 
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elevation of CRP is possibly related to the 
development of cardiometabolic diseases.11 On low 
grade inflammation, CRP is only slightly elevated 
compared to in acute inflammation. Therefore, a 
more advanced laboratory examination is needed to 
detect this lower concentration of CRP. With the 
innovation of hsCRP, a lower CRP concentration 
can be detected accurately.12 
Studies have shown a probable link between 
dietary pattern and inflammation, especially with the 
consumption of dietary fiber.13 Dietary fiber plays a 
major role on a person’s diet, however, often a 
modern Western diet contains low levels of dietary 
fiber. Low dietary fiber consumption leads to low 
fermentation metabolites, which has a crucial role on 
maintaining a healthy physiological and immune 
function. Low fiber diet is also one the causes of 
global obesity and chronic illness.14 Nevertheless, 
there are not many studies explaining dietary fiber’s 
effect on biomarker of inflammation such as hsCRP, 
particularly on the sedentary working population.  
Hopefully, this study will be able to explain better of 
the impact of dietary fiber on serum hsCRP in 
sedentary workers. 
 
Materials and methods 
 
This is a literature study assessing the association 
between dietary fiber intake and serum level of 
hsCRP on sedentary workers with source from 
scientific publications dating back to 10 years ago. 
The data-bases were PubMed and Google Scholar. 
Search term used were using the explode function 
for subgroup terms with operators (“and,”or”) for 
“dietary fiber”, “worker”, “employee”, “C-reactive 
protein”, and “dietary intake”. Hand-searching were 
used to identify further potential eligible studies. 
There were no language restrictions, however only 
publications with full texts available were included. 
More than 200 publication titles and abstract were 
screened for their relevance to this literature review. 
Information extracted from each publication 
includes the study design, location, demographic 





After screening process, three publications were 
finally included. Two publications were cross-
sectional studies, and one was a randomized clinical 
trial.  Two publications found association between 
dietary fiber and serum level of hsCRP, while one 
publication reported no association was observed 




Three studies discussing the association between 
dietary fibers and serum of hsCRP had inconsistent 
results. A cross-sectional analysis was done by 
Gibson et al.15 with 6898 workers of mean age 
41,1±9,1 years old, and mostly white men. Majority 
of subjects had moderate to high physical activity, 
with BMI above 25 kg/m2, almost 70% of subjects 
were in the never smoker group. Total fiber intake 
was 17,3±6,0 g/day assessed using 7-days estimated 
weighed food diaries. Result showed that serum 
level of hsCRP is significantly lower in the highest 
quintile of fiber intake.  A randomized controlled 
trial by Edrisi et al.16 was done on 105 overweight 
and obese workers, age 20-50 years and mean body 
mass index (BMI) was 29,14±3,37 kg/m2 with low 
physical activity. Subjects were divided into three 
energy-restricted diet groups receiving rice bran, 
rice husk powder, and a control group for 12 weeks. 
Subjects were mostly female, with moderate 
physical activity level. Dietary intake, including 
dietary fiber and two inflammatory markers IL-6 
and hsCRP were measured at baseline and endline. 
Mean total fiber intake (g/day) were 14,96±6,89 to 
19,97±7,99 collected using multiple 3-day dietary 
record. There were no significant differences found 
between rice bran and rice husk groups on serum 
levels of IL-6 and hsCRP. Nevertheless, hsCRP 
reduction in both intervention group is significantly 
higher than in the control group.  
In contrast, Khorasaniha et al.17 reported a 
different finding. Subjects were 257 male shift 
workers, age 20-60 years, mean BMI of 26,4±2,9 to 
27,3±3,2 kg/m2, and had high physical activity. 
Based on their main dietary pattern assessed using 
semi quantitative Food Frequency Questionnaire 
(FFQ), subjects were divided into three groups: 
green, yellow, and cruciferous vegetable (VEG); 
liquid oils and mayonnaise, fast food and eggs 
(LFE); tea and coffee, refined grains and spice 
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(TRS). The VEG dietary pattern was significantly 
associated with lower concentration of serum levels 
of IL-6 and TNF-a. A significant positive 
association was detected between LFE dietary 
pattern with levels of serum IL-6 and TNF-a. 
However, no significant association was found 
between VGE and LFE dietary pattern with serum 
hsCRP and between TRS dietary pattern with all of 
the inflammatory cytokines.  
Different findings between the studies might 
have been attributed to several factors that possibly 
affect hsCRP concentration. Existing studies have 
used the term inflammaging for showing that aging 
may cause chronic low grade inflammation, 
resulting an increase on hsCRP level.18 Aging causes 
an increase of fat mass, reduced sex hormones, and 
increased tissue damages from oxidative stress.19 
However, in the three studies compared on this 
review, age group of subjects are comparable. 
Previous studies found that serum hsCRP were 
higher in women compared to men.20–22 Higher 
value in women might be caused by estrogen 
fluctuation related to the menstrual cycle.23 
Furthermore, women generally have higher body fat 
accumulation compared to men, and fat is known to 
be a source of proinflammatory cytokines.24 A more 
prominent gap is seen on menopause, where a 
decrease of estrogen will stimulate the production of 
proinflammatory markers.25,26 In the study by 
Khorasaniha et al.17 subjects were exclusively male 
in comparison to the other two studies that included 
both genders.  
Ethnicity is also a main contributing factor that 
cannot be overlooked. Asians are known to have 
lower level of serum hsCRP in comparison to 
African-American, Hispanic, and European-
American.27 Genetic variation in the form of CRP 
gene polymorphism is linked to level of serum CRP 
in the circulation, different frequencies of this gene 
are seen among ethnics.28 Besides genetic, the role 
of ethnicity is also attributed to anthropometric 
measures and other risk factors, such as dietary habit 
and socio-economic status.29  Gibson et al. included 
mostly white subjects and was based in the U.K, 
while the study by Khorasaniha et al.17 was based in 
Iran. However, Edrisi et al.16 also conducted their 
study in Iran, so ethnicity factor could not elaborate 
the gap found between the two studies. As 
mentioned, anthropometric measure like BMI is 
strongly related to level of serum hsCRP. 
Overweight and obese subjects are at risk of having 
a higher hsCRP level by 1,83 and 2,63 times 
compared to those with normal body weight.30 An 
increase of white adipose tissue amount in obesity 
causes a rise of proinflammatory cytokines synthesis 
such as TNF-a and IL-6,31 which stimulates the 
production of hsCRP in liver. Edrisi et al.16 only 
worked with overweight and obese subjects, which 
had a higher mean BMI compared to the study by 
Khorasaniha et al.17  
Additionally, medications, physical activity and 
smoking habit are hypothesized to affect hsCRP 
concentration as well. Medications like statins and 
non-steroidal anti-inflammatory drugs (NSAID) 
may lower hsCRP concentration.32 Edrisi et al.16 
were the only one who excluded participants 
consuming lipid-lowering medication. Physical 
activity has an inverse relationship with hsCRP. 
Individuals with higher level of physical activity 
have lower levels of cytokines such as IL-6, IL-1, 
TNF-a, toll like receptor 4 (TLR4), and hsCRP 
compared to individuals with low levels of physical 
activity.33 Subjects included by Edrisi et al.16 mostly 
had low physical activity, on the other hand, a 
majority of subjects from the study by Khorasaniha 
et al.17 had high levels of physical activity. Contrary 
to physical activity, smoking might increase hsCRP 
concentration. Unfortunately, out of all the studies 
compared in this review only Gibson et al.15 
assessed smoking status. Edrisi et al.16 and 
Khorasaniha et al.17 excluded participants who 
smoked. Cigarette smoking triggers an immune 
response and vascular trauma which causes 
elevation of inflammation biomarker like hsCRP.34 
Dietary pattern could also affect hsCRP levels. 
High intake of simple carbohydrates such as flour 
and sugar may cause an increase of postprandial 
hyperglycemia that leads to elevation of free 
radicals, pro-inflammatory cytokines, and hsCRP.35 
Gibson et al.15 found an attenuation of the 
relationship between fiber intake and CRP and BMI 
in participant with high carbohydrate intake, defined 
as carbohydrate being ≥50% of total energy intake. 
High fat diet also affects the concentration of 
hsCRP. A high fat diet will induce migration of 
intestinal lipopolysaccharide (LPS) and free fatty 
acid to the systemic circulation, causing low grade 
inflammation.36,37 Despite that, only Edrisi et al.16 
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assessed total daily fat intake of subjects. Not only 
carbohydrate and fat intake, dietary fiber has also 
been reckoned to influence hsCRP concentration. 
Among the three studies reviewed, only two 
assessed total dietary fiber intake while Khorasaniha 
et al.17 did not. However, VEG dietary pattern are 
abundant in plants,17 and high fiber intake in plant 
model diet is related to a lower concentration of 
inflammatory markers.38 Although a lack of 
association was seen between VEG dietary pattern 
and serum level of hsCRP, a significant negative 
association was found with IL-6 and TNF-a 
concentrations. Possibly IL-6 and TNF-a is more 
sensitive to the effect dietary fiber compared to 
hsCRP, this finding is also supported by a previous 
study in post-menopausal women.27 
A few mechanisms, as seen on figure 1, have 
been stated to explain the anti-inflammatory effect 
of dietary fiber, especially on serum level of hsCRP. 
First, fermentation metabolite of fiber, also known 
as short chain fatty acid (SCFA), which are butyrate, 
acetate, and propionate is proposed to have anti- 
inflammatory effect.39  This can be seen through its 
role as an agonist on three receptors inside the body, 
the free fatty acid 2 (FFA2), free fatty acid 3 (FFA3) 
dan G protein-coupled receptor 109A (GPR109A). 
The FFA2 receptor is largely expressed on the 
immune cells including neutrophil, eosinophil, 
dendritic cells, and monocytes. The FFA3 receptor 
is mainly expressed on pancreas, spleen, adipose 
tissue and its role has been recognized on obesity 
and metabolic disorders. On the immune cells, FFA3 
is also expressed but less when compared to FFA2. 
The SCFA can activate FFA2 receptor through β-
arrestins-2 path, which causes NF-κB inhibition 
thereby resulting in anti-inflammatory effects.40 
Activation of FFA2 also decreases pro-
inflammatory cytokines such as IL-6 an d IL-8.41 
The GPR109A receptor, also known as 
hydroxycarboxylic acid receptor 2 (HCA2), is found 
at a largely on adipocytes, and expressed on 
numerous immune cells.42 On adipocytes, especially 
white adipose tissue, GPR109A decrease lipolysis 
dan macrophage activation.43 Besides being an 
agonist to the three receptors mentioned, SCFA also 
works as an inhibitor to histone deacetylases 
(HDACs), a histone protein involved in epigenetic 
DNA modification. These HDACs are mainly 
expressed on immune cells, endothelial cells, and 
vascular smooth muscle.44 When HDACs are 
inhibited, an increase of anti-inflammatory cells 
production happens. Exposure of SCFA to 
mononuclear blood cells and neutrophil causes 
inactivation of NF-κB and decreases the production 
of the pro-inflammatory cytokine TNF-a.45 
The second mechanism is the anti-inflammatory 
effect of fiber seen from polyphenols. Polyphenols 
are abundant in high fiber food and are studied for 
their antioxidant and anti-inflammatory properties. 
The anti-inflammatory effect of polyphenols is 
through their capability as a scavenger, regulating 
immune cells activity and modulating enzymes used 
in arachidonate metabolism phospholipase A2, 
cyclooxygenase (COX) and nitric oxide synthetase 
(NOS) enzyme used in arginine metabolism. On a 
molecular level, polyphenols inhibit enzymes on 
inflammation process like COX-2, lipoxygenase 
(LOX) and iNOS that inhibits NF- 𝜅B and AP-1, 
also activation of mitogen activated protein kinase 
(MAPK), protein kinase-C, and nuclear factor 
erythroid 2-related factor.46 
Obesity is one of the causes of low grade 
inflammation.7. Weight-related anti-inflammatory 
effect of dietary fiber is through adiponectin. This is 
the third mechanism proposed. Adiponectin plays a 
role on regulating insulin sensitivity, also has anti-
atherosclerotic and anti-inflammatory properties.47 
On obese subjects, adiponectin level on the blood 
will decrease, and it is cause by the elevation of  
inflammatory mediators like TNF-a which inhibits 
genes that synthesize adiponectin.48 Adiponectin 
levels in the body is inversely proportional to the 
level of serum hsCRP. The adipose tissue contains 
mRNA CRP. This shows that potentially 





Dietary fiber is an essential component of an 
individual’s diet. Anti-inflammatory effect of 
dietary fiber can be seen on serum hsCRP. Dietary 
fiber may lower hsCRP serum through SCFA, 
polyphenols, and adiponectin. Through these 
various mechanisms, dietary fiber is possibly linked 
to the prevention of low grade inflammation and its 
related diseases. Currently, the number of studies 
covering the association between dietary fiber and 
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hsCRP on sedentary workers are very limited, and 
have inconsistent outcomes. In the future, further 
studies evaluating the association between dietary 
fiber and serum hsCRP concentration on sedentary 
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Figure 1. Effect of Dietary Fiber Intake on Serum hsCRP 
COX2: cyclooxygenase 2, FFA: free fatty acid, GPR: G protein-coupled receptor, hsCRP: high sensitivity C-
reactive protein, HDACs: histone deacetylases, IL-6: interleukin 6, LOX: lipoxygenase, iNOS: nitric oxide 
synthetase, NO: nitric oxide, NF-𝜅B: nuclear factor kappa B, SCFA: short chain fatty acid. 
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